Central West Adult Symptom Management Kit. CCAC & Nursing Provider Information Package

Similar documents
Symptom Relief Kit. Guidelines

May Just in Case Box: GUIDELINES

Policy for Anticipatory Prescribing and Just in Case Bags

Licensed Pharmacy Technicians Scope of Practice

Symptom Relief Kit: Innovative Symptom Control in Palliative Care

Drug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06

Medical Aid in Dying (MAID) Update July 14, 2016

Organization and administration of services

Penticton & District Community Resources Society. Child Care & Support Services. Medication Control and Monitoring Handbook

Private Controlled Drugs Prescribing Self-Assessment

Also, you must acknowledge that you understand the following by signing and dating this sheet:

INSITE : Medication Management for Long-Term Care

VERMONT. Introduction to Medical Aid in Dying

ASSISTING STUDENTS WITH MEDICATIONS

Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement

ASSISTING STUDENTS WITH MEDICATIONS

POLICIES, PENALTIES AND PROCEDURES

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

5. returning the medication container to proper secured storage; and

Supporting Students with Medical Conditions January 2018

2. Short term prescription medication and drugs (administered for less than two weeks):

(b) Is administered via a transdermal route; or

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

BEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I. The presentation was created by

NEW JERSEY. Downloaded January 2011

LOUISIANA. Downloaded January 2011

Legal Issues in Managing Opioid Abuse. Gwen Dayton, JD

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Colorado End-of-Life Options Act

Texas Administrative Code

ASSISTING STUDENTS WITH MEDICATIONS AND THEIR HEALTHCARE NEEDS

San Andreas Regional Center Health-Related Best Practices Residential Services, Supported Living & Adult Day Programs

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

Professional Standard Regarding Medical Assistance in Dying

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives

VNAA Blueprint for Excellence PATHWAY TO BEST PRACTICES

(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-

The Carer Support Needs Assessment Tool (CSNAT) intervention. Professor Gunn Grande

MINNESOTA. Downloaded January 2011

In- Home Chart: Maximizing Palliative Practice

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW

MINNESOTA BOARD OF PHARMACY

Please adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

Medication Management and Use. Anadolu Medical Center. August, Departman Tarih

North West Residential Support Services Inc. Policies & Procedures PROCEDURES FOR THE ADMINISTRATION OF MEDICATION IN SHARED HOMES

NWN Push Partner Plan

Administration of Oral Prescription Medication Procedure Page 1 of 6

PHARMACEUTICALS AND MEDICATIONS

QAPI Making An Improvement

3. Practicing fraud, deceit, or misrepresentation in the practice of medicine.

CONTROLLED DRUG GUIDE FOR CARE HOMES

Medicine Management Policy

7.200 DONATION OF UNUSED MEDICATIONS, MEDICAL DEVICES AND MEDICAL SUPPLIES

Expected Death in the Home Protocol EDITH. Guidelines for Implementation

Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

PROPOSAL TO LEGALISE VOLUNTARY ASSISTED DYING IN VICTORIA

A Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS

MEDICATION MONITORING AND MANAGEMENT Procedures

Maine Chronic Pain Collaborative 2 (ME CPC2) Chronic Pain Management Change Package for Primary Care Practices

Expected Death in the Home Protocol EDITH. Guidelines

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

Champlain Community Care Access Centre

REGULATION MARKUP REGULATION NO. 2

Pharmacy Pain Management Protocol Pharmacy Policy and Protocol

Objectives. Institutional Pharmacy Practice. Medicare, Medicaid, What s the difference? Medicare, Medicaid, What s the difference?

WRHA Pallia*ve Care Program February Lori Embleton, Program Director Mike Harlos, Medical Director

Readmission Reduction: Patient Interviews. KHA Quality Conference March, 2018

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

Advance Care Planning: Backgrounder. OMA s End-of-Life Care Strategy April 2014

Safe & Sound: How to Prevent Medication Mishaps. A Family Caregiver Healthcare Education Program. A Who What Where Why When Tool Kit

Entrustable Professional Activities (EPAs) for Rural Family Medicine

Policies Approved by the 2017 ASHP House of Delegates

Just in Case Medication

Medication Administration in School

Participation in the Vaccines for Children Program ALL providers servicing our members between the ages of 0-20 are to register with the Vaccine

The Paediatric First Aiders at Inspire Academy are Charlotte Knight, Alicia Fowler and Sherece Lord.

Health Information and Quality Authority Regulation Directorate

Disposing of Medical Waste A Quick-Reference Guide

Mount Pleasant School Supporting Children with Medical Conditions

Hospice Continuous Home Care LEGACY HOSPICE

Woodside Primary Academy First Aid Policy

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

Review dates may alter if any significant changes are made

Medication Management: Is It in Your Toolbox?

Health UNIT DOSE. c. Florida Statutes, Chapter 893, Drug Abuse Prevention, and Control

Policies and Procedures for LTC

Aranesp (Darbepoetin) for Renal Anaemia

DECEMBER 6, 2016 MEDICAL ASSISTANCE IN DYING GUIDANCE FOR PHARMACISTS AND PHARMACY TECHNICIANS

POLICY TITLE: Administering Medications POLICY NO: 561 PAGE 1 of 5 MEDICATIONS

CHAPTER 17 PHARMACEUTICAL SERVICES

THE TEXAS GUIDE TO SCHOOL HEALTH PROGRAMS 251

Good Pharmacy Practice in Spanish Community Pharmacy

Patient Reference Guide. Palliative Care. Care for Adults

9/13/2018 MANAGING THE BIG 5 : FINANCES FOR CLINICAL LEADERS PURPOSE LEARNING OUTCOMES

NURSING FACILITIES: FRIENDS OR FOES? Marie C. Berliner Joy & Young, LLP Austin, Texas (512)

KING S HOUSE SCHOOL FIRST AID & MEDICINES AND MEDICAL CONDITIONS MANAGEMENT POLICY

Student/School Health Services SP 6.129

Transcription:

Central West Adult Symptom Management Kit CCAC & Nursing Provider Information Package What is the Central West (CW) Symptom Management Kit (SMK)? The CW SMK is a standardized package of medications and related medical supplies provided to a patient who is approaching end-of-life (EOL) for the purpose of relieving unanticipated or rapidly escalating symptoms. It can be accessed by a prescribing physician, the visiting nurse in the community and authorized by the CW Community Care Access Centre (CCAC). Why order a SMK? While it is predictable that patients facing EOL are likely to experience increasing symptoms, sometimes the timing of those symptoms are not is not always predictable. Having an SMK available in the home ensures that the visiting nurse has an evidence based tool kit and instructions to make it possible for the nurse to respond quickly and appropriately to ease a patient s unanticipated or rapidly escalating symptoms. At this time, SMK is the only available option for emergency symptom management for in-home patients when the patient s physician is not immediately available. The SMK is not intended to replace the need for proper clinical assessment leading to well defined care plans that properly identify potential issues. Responsible care planning would include the service providers communicating during the course of the care to ensure that appropriate PRN medications are in place for the patient. When should the SMK be ordered? The decision regarding when the SMK should go into the home should be part of the development of the patient s overall plan of care. The development of the plan May 2016 Page 1

should involve the patient, the patient s family, the most responsible physician and the community nurse and any other members of the patient s care team. Timing of the placement of the SMK requires careful consideration. Placing the SMK in the home prematurely may result in the expiry of the medication. Placing the SMK in the home too late in the patient s disease process could cause delay in the management of his/her symptoms and may result in a Emergency Room (ER) or hospital admission. Patients who are identified as End of Life, have a Palliative Performance Scale (PPS) or less, are deteriorating rapidly and/or has a CCAC MIS Service Recipient Code of 95 should have a SMK in place. Contraindications to ordering a SMK: A SMK is contraindicated for clients at home when: the patient s death is imminent and specific medications should be ordered for end-of-life care; the patient is a child/adult whose weight is such that medications and/or dosages require special consideration; the patient is incapable and there is no caregiver in the home who can be responsible for the SMK; there is evidence of substance abuse by the patient and/or family and no effective plan can be implemented to prevent medication misuse; there is evidence that the medications in the SMK could be used in ways other than the intended purpose; and/or the security of the SMK cannot be guaranteed in the home. Process for Ordering a SMK for the Home: 1. The Physician, the Community Nurse and/or the CCAC Care Coordinator, in collaboration determines a patient s need for a SMK based on the PPS, the May 2016 Page 2

patient s anticipated symptoms and other indications with in the last few months of life. 2. The Physician completes the SMK prescription form (CCAC may need to send a copy of the form and physician guideline) and faxes it to the CCAC. If the physician does not have facilitated access they will need to call in or complete application form for access (see physician guidelines for SMK). 3. The Care Coordinator orders the SMK supplies (IVKIT86) for delivery with SMK medications according to the urgency on the form ( same day or next day ). The SMK prescription is faxed to both Calea and the nursing agency. If Calea receives the SMK prescription directly from the physician, they will forward it to the CCAC (noting copy ) and request a supply order. 4. The Pharmacist from Calea prepares the medications and arranges for delivery with the supplies as indicated. 5. If the medications are ordered from another pharmacy, the Care Coordinator will still order the supplies (IVKIT86) and confirms with Calea that the medications are being delivered by another pharmacy. 6. The medications will be delivered in a separate bag from the kit contents. The nurse will combine these and combines the medications and the kit. Contents 1. Tupperware like storage container 2. Medications 3. Supplies 4. Copy of the prescription Indications for Accessing the SMK: the patient has sudden symptoms that cannot be managed at home by the medications already available for the patient or, it is not possible to access the patient s physician/np or pharmacy quickly enough to relieve the patient s symptoms through additional prescriptions, or May 2016 Page 3

the symptoms are of such intensity, that without the SMK, a visit to the ER is required. Process for the Administration of the Medications from the SMK: When the patient displays symptoms that require use of the medications contained in the SMK, the nurse in the home contacts the physician/np for discussion. The medications is administered as per the physician s order and documented. As the SMK is not replenished, care planning to ensure ongoing symptom management is essential as the medications in the kit will only provide coverage for 12-24 hours. The nurse must contact the physician/np to discuss adequate on-going prn medications. If the nurse is unable to contact the physician/np when access to the kit is required, the nurse administers the medications, based on the indication provided in the SMK orders for the particular medication. The nurse informs the physician/np as soon as possible. The utilized medications are now part of the treatment plan for the patient and are not returned into the SMK. When the kit is no longer needed in the home, the nurse instructs the family on how to dispose of the kit and provides feedback in the discharge report to the CCAC Care Coordinator. Disposal of the SMK & Unused Medications: The SMK is for the use of the designated patient only. Contents may not be used by anyone else. Both Legislation (The Pharmacy Act) and the Standards of Practice for Pharmacists require that any medications and/or supplies remaining in the kit, that have been ordered for a patient as part of the SMK must be disposed of to be destroyed after it is no longer required (ie after patient has died).the nurse must count and record in the patient chart any opioids and controlled substance remaining. The nurse instructs the family/caregivers to either return unused medications to their pharmacy or arrange for a waste pick up by Calea through the CCAC Care Coordinator. May 2016 Page 4

References 1. https://www.cancercare.on.ca/cms/one.aspx?portalid=1377 Symptom Management Guidelines 2. The palliative medication kit: an effective way of extending care in the home for patients nearing death. (English) By: Wowchuk SM; Wilson EA; Embleton L; Garcia M; Harlos M; Chochinov HM, Journal Of Palliative Medicine [J Palliat Med], ISSN: 1557-7740, 2009 Sep; Vol. 12 (9), pp. 797-803; Publisher: Mary Ann Liebert, Inc.; PMID: 19624267 3. Towards a basic drug kit for the dying patient. (English) By: Fürst CJ; Lindqvist O; Tishelman C, Current Opinion In Supportive And Palliative Care [Curr Opin Support Palliat Care], ISSN: 1751-4266, 2012 Sep; Vol. 6 (3), pp. 386-90; Publisher: Lippincott Williams & Wilkins; PMID: 22801469 4. The Use of Emergency Medication Kits in Community Palliative Care: An Exploratory Survey of Views of Current Practice in Australian Home-Based Palliative Care Services. (English) By: Bullen T; Rosenberg JP; Smith B; Maher K, The American Journal Of Hospice & Palliative Care [Am J Hosp Palliat Care], ISSN: 1938-2715, 2015 Sep; Vol. 32 (6), pp. 581-7; Publisher: Sage Publications; PMID: 24871345 5. The Use of Emergency Medication Kits in Community Palliative Care. Bullen, Tracey; Rosenberg, John P.; Smith, Bradley; Maher, Kate; American Journal of Hospice & Palliative Medicine, Sep2015; 32(6): 581-587. (7p) (Journal Article - research, tables/charts) ISSN: 1049-9091 PMID: 24871345 AN: 109825077 6. Supporting Family Caregivers With Palliative Symptom Management: A Qualitative Analysis of the Provision of an Emergency Medication Kit in the Home Setting. Rosenberg, John P.; Bullen, Tracey; Maher, Kate; American Journal of Hospice & Palliative Medicine, Aug2015; 32(5): 484-489. (6p) (Journal Article - research) ISSN: 1049-9091 PMID: 24803586 AN: 109819046 May 2016 Page 5

May 2016 Page 6